Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,558
Closed -$167K 1983
2025
Q1
$167K Sell
11,558
-3,435
-23% -$65.7K ﹤0.01% 1692
2024
Q4
$333K Buy
14,993
+10,057
+204% +$276K ﹤0.01% 1643
2024
Q3
$135K Buy
4,936
+705
+17% +$18.2K ﹤0.01% 1741
2024
Q2
$97.4K Sell
4,231
-674
-14% -$18K ﹤0.01% 1708
2024
Q1
$146K Buy
4,905
+768
+19% +$23.7K ﹤0.01% 1697
2023
Q4
$116K Buy
4,137
+292
+8% +$8.22K ﹤0.01% 1746
2023
Q3
$98.9K Sell
3,845
-248
-6% -$8.55K ﹤0.01% 1758
2023
Q2
$169K Sell
4,093
-792
-16% -$35.7K ﹤0.01% 1645
2023
Q1
$231K Buy
+4,885
New +$243K ﹤0.01% 1529

Other funds holding MNRO

Amundi's MNRO Position: Q2 2025 in Review

Amundi sold out of Monro (MNRO) in Q2 2025, closing a stake of 11,558 shares — an estimated $167K sold.

Amundi first reported a position in MNRO in Q1 2023 and held it in 9 quarters. The position peaked at $333K in Q4 2024. 189 funds tracked by Wall St. Rank hold MNRO as of Q2 2025.

  • Amundi reported no remaining Monro position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 11,558 Monro shares in Q2 2025, an estimated $167K.
  • Amundi first reported a position in Monro in Q1 2023 and held it in 9 quarters.
  • Amundi's Monro position peaked at $333K in Q4 2024.
  • 189 funds tracked by Wall St. Rank held Monro as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.